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Objective: Bilateral hypertrophic olivary degeneration on
brain MRI has been reported in a few metabolic, genetic
and neurodegenerative disorders, includingmitochondrial
disorders. In this report, we sought to analyse whether
bilateral symmetrical inferior olivary nucleus hypertrophy
is specifically associated with mitochondrial disorders in
children.
Methods: This retrospective study included 125 chil-
dren (mean age, 7.66 5 years; male:female, 2.6:1)
diagnosed with various metabolic and genetic disor-
ders during 2005–2012. The routine MRI sequences (T1
weighted, T2 weighted and fluid-attenuated inversion–
recovery sequences) were analysed for the presence
of bilateral symmetrical olivary hypertrophy and cen-
tral tegmental tract or dentate nuclei signal changes.
The other imaging findings and the final diagnoses
were noted.
Results: The cohort included patients with Leigh and
Leigh-like syndrome (n525), other mitochondrial dis-
eases (n525), Wilson disease (n540), Type 1 glutaric
aciduria (n5 14), maple syrup urine disease (n5 13), giant
axonal neuropathy (n55) and L-2 hydroxy glutaric
aciduria (n53). Bilateral inferior olivary nucleus hypertro-
phy was noted in 10 patients, all of whom belonged to the
Leigh and Leigh-like syndrome group.
Conclusion: Bilateral hypertrophic olivary degeneration
on MRI is relatively often, but not routinely, seen in
children with Leigh and Leigh-like syndrome. Early de-
tection of this finding by radiologists and physicians may
facilitate targeted metabolic testing in these children.
Advances in knowledge: This article highlights the
occurrence of bilateral hypertrophic olivary nucleus de-
generation on MRI in children with Leigh and Leigh-like
syndrome, compared with other metabolic disorders.
Hypertrophic olivary degeneration is a rare form of neuronal
degeneration that results from disruption of the afferent
fibres to the inferior olive within the dentato-rubro-
olivary tract, otherwise known as the triangle of Guillain–
Mollaret.1 The first description of the enlargement of the
inferior olivary nucleus was by Oppenheim, in Germany,
in his post-mortem study.2 Since then, a number of reports
describing the clinical, histopathological and MRI findings
have been published.3–7
A variety of insults can lead to hypertrophic olivary de-
generation, of which the most commonly reported are
haemorrhage, infarct, trauma, surgery or tumour.8–13 The
lesions result in loss of synaptic input to the inferior olivary
nucleus and in trans-synaptic neuronal degeneration.5
This has been considered a unique morphological form of
trans-synaptic degeneration because it is associated with
hypertrophy rather than atrophy of the affected structure.14
Histopathologically, it is characterized by neuronal en-
largement of the olivary neurons, neuronal loss, vacuolation,
demyelination and marked astrogliosis.3,5,7 It is most often
unilateral when it is secondary to a structural lesion, al-
though bilateral changes are recognized8,15 and may occur if
both the superior cerebellar peduncle and the central teg-
mental tracts are involved.16,17
Bilateral hypertrophic olivary degeneration has been reported
in a few metabolic, genetic, neurodegenerative and toxic
disorders.18–24 It has been previously noted that the presence of
hypertrophic olivary degeneration in the appropriate clinical set-
ting should alert the clinician to the possibility of a mitochondrial
disorder.20 In addition, the reports on hypertrophic olivary de-
generation in paediatric patients are limited.15,25–27 In this report,
we sought to analyse whether bilateral symmetrical inferior olivary
nucleus hypertrophy is specifically associated with mitochondrial
disorders in children.
METHODS AND MATERIALS
This retrospective study was carried out in the departments of
neurology and neuroimaging and interventional neuroradiology at
a university hospital in South India. The study included 125 chil-
dren [mean age: 7.665 years; male:female (M:F), 2.6:1] diagnosed
with various metabolic and genetic disorders seen over a period of 8
years (2005–2012). The cohort included three groups: (1) 25
children with Leigh and Leigh-like syndrome (mean age: 3.462.6
years; M:F, 3:1); (2) 25 children with mitochondrial disorders other
than Leigh syndrome (mean age: 8.864.3 years); (3) 75 children
with other metabolic and genetic disorders, which included Wilson
disease, Type 1 glutaric aciduria, maple syrup urine disease, giant
axonal neuropathy and L-2 hydroxy glutaric aciduria. These 75
patients were selected from a database of children with metabolic
disorders and an MRI available for review. The inclusion of these
disorders was based on their propensity to involve the brainstem,
central tegmental tracts or dentate nuclei on MRI. This inclusion
criterion was adopted to assess the presence of hypertrophic olivary
degeneration in relation to the other components of the Guillain–
Mollaret triangle. Metabolic disorders without propensity to involve
the brainstem or dentate nuclei were excluded.
All patients with Leigh and Leigh-like syndrome fulfilled the criteria
described by Rahman et al.28 All patients underwent sequencing of
the complete mitochondrial genome and the SURF1, one of the
most common nuclear genes consistently associated with Leigh
syndrome and cytochrome c oxidase (COX) deficiency. Four of
them showedmutations in SURF1. Three of these patients hadCOX
deficiency in both histopathology and respiratory chain enzyme
assays. The fourth patient did not have the test for COX. The clinical
and imaging findings in these four patients have already been de-
scribed.29,30 The diagnosis of other mitochondrial disorders were
based on the modified Walker criteria for definite mitochondrial
disorders by Bernier et al.31 All of them had clinical features con-
sistent with a mitochondrial encephalomyopathy along with one or
more of the following: (1) histopathological evidence of ragged red
fibres or COX deficiency; (2) residual respiratory chain complex
activity of ,20% in muscle tissue compared with controls using
citrate synthase as the reference enzyme; (3) known pathogenic
mutations in the mitochondrial or nuclear genome. This group
included polymerase gamma (POLG)-related disorder (n5 4);
mitochondrial encephalomyopathy lactic acidosis and stroke
syndrome-like episodes (n5 3); Lebers hereditary optic neuropa-
thy plus syndrome (n5 1); myoclonic epilepsy with ragged red
fibres syndrome (n52); and other non-syndromic mitochondrial
disorders (n515).
The details of the non-mitochondrial group and the criteria for
diagnosis in each disease group are as follows: Wilson disease
(n5 40; age range: 6–16 years; M:F, 1.2:1)—the presence of
Kayser–Fleischer rings by slit lamp, low serum caeruloplasmin
and raised 24h urinary copper; Type 1 glutaric aciduria (n5 14;
age range: 8 months to 6 years; M:F, 1:1.3)—characteristic clinical
and imaging findings with the presence of elevated glutaryl car-
nitine on tandem mass spectrometry and/or urinary organic acid
estimation; maple syrup urine disease (n5 13; age range: 14 days
to 11 years; M:F, 1:1.6)—confirmed by elevated branched chain
amino acids on tandem mass spectrometry of dried blood spots
and/or high-performance liquid chromatography; giant axonal
neuropathy (n5 5; age range: 4–6 years; M:F, 4:1)—the presence
of characteristic morphological features of frizzy hair, peripheral
neuropathy and cerebellar signs along with giant axons on sural
nerve biopsy; L-2 hydroxy glutaric aciduria (n5 3; age range:
16–18 years; M:F, 2:1)—elevated L-2 hydroxy glutaric acid on
urinary organic acid estimation.
MRI was performed, after obtaining informed consent, using a
Siemens Magnetom Vision 1.5-T MRI scanner (Erlangen, Germany)
using standard procedures and protocols. Spin echo T1 weighted
[repetition time (TR)5650ms and echo time (TE)514ms] images
in axial and sagittal planes were taken, with an acquisition time
of 2.5min, a matrix of 2563 256 and a 230-mm field of view (FOV).
T2 weighted images (TR54000ms and TE5120ms) were acquired
in axial and coronal planes. Fluid-attenuated inversion–recovery
(FLAIR) sequences were obtained in the axial plane (TR59000ms,
TE5119ms, inversion time52457ms). The slice thickness was
5mm. MRI sequences included T1 weighted (with and without
contrast), T2 weighted and FLAIR in all.
For those who underwent imaging in the Achieva 3.0-T MRI
scanner (Philips Medical Systems, Best, Netherlands), MRI scans
were obtained by first performing a three-plane localizer scan,
followed by an axial turbo spin-echo T2 weighted scan (TR/
TE5 3270/80ms; flip angle5 90°; FOV5 250 3 250mm; ac-
quired voxel size5 0.89/1.21/5.00mm; and slice thickness/
gap5 5/1mm); T2 weighted FLAIR sense (TR/TE5 11000/
120ms; flip angle5 90°; FOV5 250 3 250mm; acquired voxel
size5 0.96/1.79/5.00mm; and slice thickness/gap5 5/1mm).
Three-dimensional magnetization-prepared rapid acquisition
gradient recalled echo volumetric scans of the whole brain were
acquired (TR/TE5 8.3/3.8ms; sense factor5 1.5; flip angle5 8°;
FOV5 256; acquired voxel size5 1/1/1mm).
Findings on MRI at the level of the olives were evaluated by two
neurologists (ABT and PSB) and one neuroradiologist (HRA) with
emphasis on the lateral placement, signal intensity and hypertro-
phy of the lesions. If the oval shape of the olive had become round
with an apparent bulge, it was classified as hypertrophic.5 Addi-
tional features noted include the presence of hyperintensity of the
dentate nuclei and central tegmental tract and midbrain signal
changes. The clinicians were not blinded to the diagnoses. The
neuroradiologists reviewed the images independently. A consensus
was reached when there was a disagreement.
RESULTS
Of the 125 MRI scans reviewed, 10 showed bilateral hypertro-
phic olivary degeneration. The inferior olivary nuclei were dem-
onstrated as areas of high signal intensity on the T2 weighted and
FLAIR images in all of the patients (Figure 1). The shape of the
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olivary nucleus was round in all patients with loss of serrated
appearance (Figure 1). On T1 weighted images, the nucleus
appeared isointense. A focal enhancement of the hypertrophic
olivary nuclei was noted in one patient. All the patients with an
inferior olivary hypertrophy belonged to the mitochondrial dis-
ease group and had a diagnosis of Leigh and Leigh-like syndrome,
as defined by the criteria of Rahman et al.28 The phenotypic
features of these 10 patients are shown in Table 1. Of the 25
patients who fulfilled the diagnostic criteria for Leigh syndrome,
there were 5 patients with Leigh syndrome secondary to SURF1
mutation (4 patients withmutation positive and the sibling of one
of the patients with a mutation). All five showed inferior olivary
hypertrophy. Two other patients with COX deficiency in the non-
syndromic mitochondrial group, but without a Leigh phenotype,
did not show evidence of hypertrophic olivary degeneration.
Dentate nucleus hyperintensity was noted in five patients, lesions
of the pontine tegmentum in two and central tegmental tract in
four patients in this group. The olivary degeneration occurred
with or without central tegmental tract and dentate nucleus
hyperintensity (Figure 2). The duration of illness in these patients
at the time ofMRI ranged from 1month to 5 years. In two patients
with Leigh-like syndrome (Patients 9 and 10), the olivary de-
generation was noted on follow-up images.
In the Wilson disease group, although 10 patients had bilateral
central tegmental tract involvement, neither dentate nucleus
hyperintensity nor inferior olivary hypertrophy was present. Out
of the 14 patients with Type 1 glutaric aciduria, 9 had both central
tegmental tract and dentate nucleus hyperintensities and none
had hypertrophic olivary degeneration. In the giant axonal neu-
ropathy, three patients had dentate nucleus hyperintensity, but
none had central tegmental tract or olivary nucleus hypertrophy.
In maple syrup urine disease, there was extensive involvement of
the brainstem, cerebellum and dentate nuclei in all patients as-
sociated with diffusion restriction. The medullary signal changes
involved both the dorsal and ventral medulla in some patients,
and the inferior olivary nucleus was not clearly visible. All patients
with L-2 hydroxy glutaric aciduria had dentate nucleus hyper-
intensity but did not have central tegmental tract or olivary nu-
cleus involvement.
DISCUSSION
This report describes the occurrence of hypertrophic olivary de-
generation in a cohort of children with metabolic and genetic
disorders. Our results suggest that this finding is most often asso-
ciated with a mitochondrial disorder in children, especially Leigh
and Leigh-like syndrome. Reports on bilateral hypertrophic olivary
degeneration resulting from genetic ormetabolic disorders are rare.
There are a number of reports describing hypertrophy of the olivary
nucleus in mitochondrial disorders.19,20 In a series of 26 children
with POLG-related disorders, bilateral hypertrophic olivary de-
generation was observed in 2 patients, and 1 of them had the
clinical correlate of palatal myoclonus.19 It has also been described
in Leigh syndrome secondary to SURF1mutations.20 Review of the
previously published MRI studies in Leigh syndrome patients
identified few reports describing the involvement of the olives.32–34
It is noteworthy that all but one of the patients in these reports had
COX deficiency and SURF1mutations. The only exception was the
patient with Leigh syndrome secondary to pyruvate dehydrogenase
deficiency in the report by Medina et al.34 In this cohort, the hy-
pertrophic olivary degeneration was seen in 40% of the children
with Leigh and Leigh-like syndrome and was not observed in other
groups of metabolic disorders. Although all patients with SURF1
mutation had hypertrophic degeneration, it was also seen in
patients without the mutations, indicating that it is not exclusively
seen in this subtype of children with Leigh syndrome. In addition,
two children with cytochrome c deficiency but without the Leigh
syndrome phenotype did not show this finding. Nevertheless,
analysis of the whole cohort of children with metabolic and genetic
disorders indicates that this imaging observation is more com-
monly seen in children with Leigh and Leigh-like syndrome. None
of the patients with mutation-positive POLG-related disorder had
inferior olivary hypertrophy in the present study.
The bilateral inferior olivary hypertrophy seen in these childrenwas
not always associated with lesions of the central tegmental tract or
dentate nucleus, suggesting an independent involvement of these
nuclei in mitochondrial disorders. Neuropathological studies in
mitochondrial diseases have shown that the olivary cerebellar sys-
tem is involved in a variety of mitochondrial disorders and plays an
important role in the pathogenesis of ataxia seen in these patients.35
Figure 1. MRI brain fluid-attenuated and inversion–recovery axial views in different patients showing bilateral symmetrical signal
changes in the inferior olivary nucleus. The margins of the nuclei are round and an apparent bulge (indicated by arrows) is noted.
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Table 1. Clinical and laboratory features of patients with bilateral symmetrical hypertrophic olivary degeneration
Patients Age Sex
Duration of
illness at the
time of MRI
Clinical
features
Laboratory
tests
MRI findings
other than
hypertrophic
olivary
degeneration
Final
diagnosis
Patient 1 5 years M 2 years
Developmental
delay, episodic
neuroregression,
hypotonia, sighing
respiration,
ophthalmoparesis,
nystagmus,
dystonia, and
demyelinating
neuropathy
Elevated serum
lactate
Bilateral
symmetrical signal
changes in caudate
putamen, central
tegmental tract and
dentate
Leigh
syndrome
Patient 2 4 years F 6 months
Developmental
delay, episodic
neuro-regression,
hypotonia, sighing
respiration, tremor
of hands, titubation,
ataxia,
ophthalmoparesis,
and nystagmus
Elevated serum
lactate and CSF
lactate, elevated
lactate–pyruvate
ratio
Bilateral
symmetrical signal
changes in dentate
nuclei, cerebellar
white matter and
putamen. Lactate
peak on MR
spectroscopy
Leigh
syndrome
Patient 3
2.5
years
F 2 years
Developmental
delay, episodic
neuroregression,
hypotonia, sighing
respiration,
ophthalmoparesis,
dystonia,
hypertrichosis and
family history of
retinitis pigmentosa
Elevated serum
lactate.
Novel SURF1
mutation
Bilateral
symmetrical signal
changes in caudate,
putamen thalamus,
mid-brain and
cerebellar white
matter
Leigh
syndrome
Patient 4
18
months
M 6 months
Developmental
delay,
neuroregression,
hypotonia, sighing
respiration,
ophthalmoparesis,
nystagmus, ataxia,
dystonia,
hypertrichosis,
family history of
Leigh syndrome in
the younger siblinga
Elevated serum
lactate, COX
deficiency on
histopathology,
,20% activity of
complex IV on
respiratory chain
enzyme assays.
Novel SURF1
mutation
Bilateral
symmetrical signal
changes in caudate,
putamen,
subthalamic
nucleus, substantia
nigra, central
tegmental tract,
periaqueductal grey
matter
Leigh
syndrome
Patient 5 3 years F 1 month
Developmental
delay,
neuroregression,
ataxia, sighing
respiration,
hypertrichosis,
family history of
Leigh syndrome in
elder sibling
Elevated serum
lactate, COX
deficiency on
muscle biopsy.
,20% activity of
complex IV on
respiratory chain
assays. Novel SURF1
mutation
Bilateral
symmetrical signal
changes in
substantia nigra and
posterior
periventricular
white matter and
speck of
hyperintensity in
putamen
Leigh
syndrome
(Continued)
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This particular study involved 14 patients with definite mito-
chondrial diseases. There was variable neuronal loss in the dentate
nuclei, inferior olives and Purkinje cell system in these patients
along with severe deficiency of respiratory chain enzymes in the
remaining neurons. This shows that the inferior olivary
nucleus is vulnerable to energy deficiency in patients with
mitochondrial disorders. The MRI correlates of these patients
are not provided in the report. Nevertheless, it will be in-
teresting to see if the microscopic changes in these patients are
associated with imaging changes.
Neuropathological studies in Leigh syndrome patients also have
highlighted the occurrence of neuronal loss and vacuolar de-
generation in inferior olives.35–38 The finding was most often
Table 1. (Continued)
Patients Age Sex
Duration of
illness at the
time of MRI
Clinical
features
Laboratory
tests
MRI findings
other than
hypertrophic
olivary
degeneration
Final
diagnosis
Patient 6 6 years M 3 years
Developmental
delay, hypotonia,
ataxia,
ophthalmoparesis,
sighing respiration
hypertrichosis,
hypopigmented hair
and skin
Elevated lactate,
COX deficiency on
muscle biopsy,
,20% activity of
complex IV on
respiratory chain
enzyme assays.
Novel SURF1
mutation
Bilateral
symmetrical signal
changes in dentate
nuclei and central
tegmental tract
Leigh
syndrome
Patient 7a 2 years M 9 months
Developmental
delay,
neuroregression,
hypotonia, sighing
respiration,
ophthalmoparesis,
nystagmus, ataxia,
dystonia and
hypertrichosis
Elevated serum
lactate. Elder sibling
has Leigh syndrome
with COX
deficiency and
SURF1 mutation
Bilateral
symmetrical signal
changes in caudate
putamen,
subthalamic
nucleus, substantia
nigra
Leigh
syndrome
Patient 8 9 years M 6 months
Episodic
encephalopathy,
tremor, ataxia and
ocular bobbing
Normal serum
lactate.
Subsarcolemmal
aggregation of
reaction products
on succinate
dehydrogenase
enzyme staining on
muscle biopsy
Bilateral
symmetrical signal
changes in thalamus
and central
tegmental tract
Leigh-like
syndrome
Patient 9 5 years M 1 year
Progressive
extrapyramidal
syndrome,
generalized dystonia
Elevated serum
lactate, multiple
complex deficiency
(,20% activity) on
respiratory chain
enzyme assays
Bilateral
symmetrical signal
changes in caudate
and putamen
Leigh-like
syndrome
Patient 10 5 years M 5 years
Progressive
extrapyramidal
syndrome,
generalized dystonia
Elevated serum
lactate, elevated
serum alanine,
subsarcolemmal
accumulation of
reaction products
on succinate
dehydrogenase
enzyme staining on
muscle biopsy
Bilateral
symmetrical signal
changes in caudate
and putamen
Leigh-like
syndrome
COX, cytochrome c oxidase; CSF, cerebrospinal fluid; F, female; M, male.
Patient 3 reported in Sonam et al29,30 and Patients 4, 5 and 6 in Sonam et al.29
aSibling of Patient 4.
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noted in those patients who presented after the first year of life.
This was attributed to the delayed maturation of the olivary–
cerebellar system in children, which occurs most often after
infancy. The fact that hypertrophic olivary degeneration is
present even in the presence of neuronal loss is explained by
pathological studies. The characteristic features that define
hypertrophic olivary degeneration are overall enlargement of
the olive in which convolutions are obscured.4 The neurons
appear large and deformed and show marked astroglial re-
action. Gautier and Blackwood3 had demonstrated that there is
enlargement of both grey and white matter and the increased
width of the grey lamina is in part due to hypertrophy of the
nerve cell bodies and processes. They suggest that the eventual
atrophy of the abnormal neurons is not accompanied by
shrinkage of the glial mass so that the enlarged outline of the
olive persists. This may be the explanation for hypertrophied
olives even when there is neuronal loss in mitochondrial
disorders.
The clinical correlates of the hypertrophic olivary degeneration
in children and in patients with mitochondrial disorders have
been variable. It was associated with palatal myoclonus in one
of the two patients with POLG-related disorder described by
Tzoulis et al.19 In the report by Kinghorn et al,20 a generalized
tremor was noted in a child with SURF1mutations but was not
present in two other patients. In the report of Sanverdi et al,15 none
of the four children with hypertrophic olivary degeneration had
palatal myoclonus. In the current study, two patients had a gener-
alized tremor associated with ocular bobbing. In two patients, the
clinical picture was dominated by generalized dystonia refractory to
treatment with most of the anti-dystonia medications. It is difficult
to comment about this finding in other patients, because it was not
systematically looked for in most of the young patients.
The triangle of nerve tracts involved in the genesis of hyper-
trophic olivary degeneration is referred to as the triangle of
Guillain and Mollaret.1 These dentato-rubro-olivary fibres
connect the ipsilateral red nucleus and inferior olive with the
contralateral dentate nucleus. Efferent fibres from the dentate
nucleus course through the superior cerebellar peduncle, de-
cussate in the brachium conjunctivum and then connect to
the contralateral red nucleus. The efferent fibres from the red
nucleus are connected to the olive through the central teg-
mental tract. The inferior olive is then connected to the
contralateral cerebellum via the inferior cerebellar peduncle
thus forming a triangle. It is pointed out that deafferentiating
the inferior olivary nucleus is the key factor and, typically,
lesions disrupting the superior cerebellar peduncle or central
tegmental tract lead to hypertrophic olivary degeneration.
The localization of the olivary degeneration depends on the
site of the lesion. Lesions of the red nucleus or central teg-
mental tract cause the hypertrophy of the ipsilateral nucleus
and, alternatively, the lesions of the superior cerebellar pe-
duncle or dentate nucleus cause hypertrophic olivary de-
generation on the contralateral side.9,12 Bilateral hypertrophy
occurs when the lesion involves the brachium conjunctivum
or interrupts both the central tegmental tract and superior
cerebellar peduncle.16
In the cohort of children in the present study, the hypertrophic
olivary degeneration was associated with lesions of the central
tegmental tract and dentate nucleus in most of the patients, but
also occurred independently. In patients with Wilson disease,
although 10 patients had involvement of the central tegmental
tract, hypertrophy of the inferior olivary nucleus was not ob-
served. Diffusion tensor imaging (DTI) studies in patients with
inferior olivary nucleus hypertrophy have demonstrated signal
changes in all anatomical components of the Guillain–Mollaret
triangle even when conventional MRI did not show any signs of
involvement in the other components of the Guillain–Mollaret
triangle.39,40 It was also shown that the DTI parameters can re-
flect the spatiotemporal evolution of transneuronal degeneration
associated with hypertrophic olivary degeneration (HOD) in
a manner consistent with the known pathological stages of
HOD.26 In addition, susceptibility-weighted imaging has been
utilized to study the red nucleus degeneration and atrophy in
childrenwith HOD after posterior fossa tumour resection.27 This
indicates that quantitative imaging studies may better define the
extent of the lesions in these patients and may be a future area of
research.
In conclusion, this study on children with various metabolic and
genetic disorders suggests that bilateral hypertrophic olivary de-
generation is relatively often, but not routinely, seen in children
with Leigh and Leigh-like syndrome. Nevertheless, when com-
pared with other metabolic disorders, this finding was more
commonly seen in children with Leigh and Leigh-like syndrome.
This occurred both independently and in association with central
tegmental tract and dentate nuclei involvement. The findings
suggest that bilateral hypertrophic olivary degeneration should
prompt the physician to carry out investigations to rule out
a mitochondrial disorder.
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Figure 2. MRI scan of the brain in Patient 6. Fluid-attenuated
inversion–recovery coronal and axial views showing bilateral
symmetrical signal changes indentate nuclei and inferior olivary
hypertrophy (arrows) in this patient with cytochrome c oxidase
deficiency and SURF1mutation.
BJR PS Bindu et al
6 of 8 bjr.birjournals.org Br J Radiol;87:20130478
REFERENCES
1. Guillian G, Mollaret P. Deux cas de myocl-
onies synchrones et rhythmes velopharyngo-
laryngo-oculo-diaphragmatiques. Rev Neurol
1931; 2: 545–66.
2. Oppenheim H. Uber oliven degeneration
bei atheromatose der basalen hinarterien.
Berl Klin Wochenschr 1887; 34: 638–9.
3. Gautier JC, Blackwood W. Enlargement of
the inferior olivary nucleus in
association with lesions of the central
tegmental tract or dentate nucleus. Brain
1961; 84: 341–61.
4. Anderson JR, Treip CS. Hypertrophic oli-
vary degeneration and Purkinje cell de-
generation in a case of long-standing head
injury. J Neurol Neurosurg Psychiatry 1973;
36: 826–32.
5. Kitajima M, Korogi Y, Shimomura O, Sakamoto
Y, Hirai T, Miyayama H, et al. Hypertrophic
olivary degeneration: MR imaging and patho-
logic findings. Radiology 1994; 192: 539–43. doi:
10.1148/radiology.192.2.8029428
6. Goyal M, Versnick E, Tuite P, Cyr JS,
Kucharczyk W, Montanera W, et al. Hyper-
trophic olivary degeneration: metaanalysis of
the temporal evolution of MR findings. AJNR
Am J Neuroradiol 2000; 21: 1073–7.
7. Nishie M, Yoshida Y, Hirata Y, Matsunaga M.
Generation of symptomatic palatal tremor is
not correlated with inferior olivary hyper-
trophy. Brain 2002; 125: 1348–57.
8. Salamon-Murayama N, Russell EJ, Rabin BM.
Diagnosis please. Case 17: hypertrophic
olivary degeneration secondary to pontine
haemorrhage. Radiology 1999; 213: 814–17.
doi: 10.1148/radiology.213.3.r99dc43814
9. Krings T, Foltys H, Meister IG, Reul J.
Hypertrophic olivary degeneration following
pontine haemorrhage: hypertensive crisis or
cavernous haemangioma bleeding? J Neurol
Neurosurg Psychiatry 2003; 74: 797–9.
10. Suzuki M, Takashima T, Ueda F, Fujinaga Y,
Horichi Y, Yamashita J. Olivary degeneration
after intracranial haemorrhage or trauma:
follow-up MRI. Neuroradiology 1999; 41: 9–12.
11. Hornyak M, Osborn AG, Couldwell WT.
Hypertrophic olivary degeneration after sur-
gical removal of cavernous malformations of
the brain stem: report of four cases and
review of the literature. Acta Neurochir
(Wien) 2008; 150: 149–56. doi: 10.1007/
s00701-007-1470-0
12. Choh NA, Choh SA, Jehangir M. Hypertro-
phic olivary degeneration: the forgotten-
triangle of Guillain and Mollaret. Neurol
India 2009; 57: 507–9. doi: 10.4103/0028-
3886.55587
13. Gatlin JL, Wineman R, Schlakman B, Buciuc
R, Khan M. Hypertrophic olivary degenera-
tion after resection of a pontine cavernous
malformation: a case report. J Radiol Case
Rep 2011; 5: 24–9. doi: 10.3941/jrcr.v5i3.603
14. Duchen LW. General pathology of neurons
and neuroglia. In: Greenfield H, Corsellis
JAN, Duchen LW, eds. Neuropathology.
4th edn. New York, NY: Wiley; 1984.
p. 18–9.
15. Sanverdi SE, Oguz KK, Haliloglu G. Hyper-
trophic olivary degeneration in children: four
new cases and a review of the literature with
an emphasis on the MRI findings. Br J Radiol
2012; 85: 511–16. doi: 10.1259/bjr/60727602
16. Conforto AB, Smid J, Marie SKN, Ciriaco JGM,
Santoro PP, Leite CC, et al. Bilateral olivary
hypertrophy after unilateral cerebellar infarc-
tion. Arq Neuropsiquiatr 2005; 63: 321–3.
17. Gerace C, Fele MR, Luna R, Piazza G.
Neurologial picture: bilateral hypertrophic-
olivary degeneration. J Neurol Neurosurg
Psychiatry 2006; 77: 73. doi: 10.1136/
jnnp.2005.069831
18. Kulkarni PK, Muthane UB, Taly AB, Jayaku-
mar PN, Shetty R, Swamy HS. Palatal tremor,
progressive multiple cranial nerve palsies, and
cerebellar ataxia: a case report and review of
literature of palatal tremors in neurodegen-
erative disease. Mov Disord 1999; 14: 689–93.
19. Tzoulis C, Engelsen BA, Telstad W, Aasly J,
ZevianiM,Winterthun S, et al. The spectrumof
clinical disease caused by theA467TandW748S
POLG mutations: a study of 26 cases. Brain
2006; 129: 1685–92. doi: 10.1093/brain/awl097
20. Kinghorn KJ, Kaliakatsos M, Blakely EL,
Taylor RW, Rich P, Clarke A, et al. Hyper-
trophic olivary degeneration on magnetic
resonance imaging in mitochondrial syn-
dromes associated with POLG and SURF1
mutations. J Neurol 2013; 260: 3–9. doi:
10.1007/s00415-012-6564-9
21. Otto J, Guenther P, Hoffmann KT. Bilateral
hypertrophic olivary degeneration in Wilson
disease. Korean J Radiol 2013; 14: 316–20.
doi: 10.3348/kjr.2013.14.2.316
22. Hanihara T, Amano N, Takahashi T, Itoh Y,
Yagishita S. Hypertrophy of the inferior olivary
nucleus in patients with progressive supra-
nuclear palsy. Eur Neurol 1998; 39: 97–102.
23. Cazals X, Omoumi P, Agnard P, Bibi R,
Ferquel C, Cazeneuve N, et al. Reversible
metronidazole-induced encephalopathy and
hypertrophic olivary degeneration. J Radiol
2010; 91: 304–6.
24. Seok JI, Yi H, Song YM, Lee WY.
Metronidazole-induced encephalopathy and
inferior olivary hypertrophy: lesion analysis
with diffusion-weighted imaging and appar-
ent diffusion coefficient maps. Arch Neurol
2003; 60: 1796–800. doi: 10.1001/
archneur.60.12.1796
25. Phatouros CC, McConachie NS. Hyper-
trophic olivary degeneration: case report
in a child. Pediatr Radiol 1998; 28:
830–1.
26. Meoded A, Poretti A, Ilica AT, Perez R, Jallo
G, Burger PC, et al. Diffusion tensor imaging
in a child with hypertrophic olivary de-
generation. Cerebellum 2013; 12: 469–74. doi:
10.1007/s12311-013-0448-0
27. Vossough A, Ziai P, Chatzkel JA. Red nucleus
degeneration in hypertrophic olivary degen-
eration after pediatric posterior fossa tumor
resection: use of susceptibility-weighted im-
aging (SWI). Pediatr Radiol 2012; 42: 481–5.
doi: 10.1007/s00247-011-2330-x
28. Rahman S, Blok RB, Dal HH, Danks DM,
Kirby DM, Chow CW, et al. Leigh syndrome:
clinical features and biochemical and DNA
abnormalities. Ann Neurol 1996; 39: 343–51.
doi: 10.1002/ana.410390311
29. Sonam K, Khan NA, Bindu PS, Taly AB,
Gayathri N, Srinivas Bharath MM, et al.
Clinical and magnetic resonance imaging
findings in patients with Leigh syndrome and
SURF1 mutations. Brain Dev Nov 2013. Epub
ahead of print. doi: 10.1016/j.braindev.2013.
10.012
30. Sonam K, Bindu PS, Gayathri N, Khan NA,
Govindaraju C, Arvinda HR, et al. The
double panda sign in Leigh disease. J Child
Neurol Apr 2013. Epub ahead of print. doi:
10.1177/0883073813484968
31. Bernier FP, Boneh A, Dennett X, Chow
CW, Cleary MA, Thorburn DR. Diagnostic
criteria for respiratory chain disorders in
adults and children. Neurology 2002; 59:
1406–11.
32. Farina L, Chiapparini L, Uziel G, Bugiani M,
Zeviani M, Savoiardo M. MR findings in
Leigh syndrome with COX deficiency and
SURF-1 mutations. AJNR Am J Neuroradiol
2002; 23: 1095–100.
33. Savoiardo M, Uziel G, Strada L, Visciani A,
Grisoli M, Wang G. MRI findings in
Leigh’s disease with cytochrome-c-oxidase
deficiency. Neuroradiology 1991; 33:
507–8.
34. Medina L, Chi TL, DeVivo DC, Hilal SK. MR
findings in patients with subacute necrotizing
encephalomyelopathy (Leigh syndrome):
correlation with biochemical defect. AJR Am
J Roentgenol 1990; 154: 1269–74.
Full paper: Inferior olivary nucleus hypertrophy in children BJR
7 of 8 bjr.birjournals.org Br J Radiol;87:20130478
35. Lax NZ, Hepplewhite PD, Reeve AK, Nesbitt
V, McFarland R, Jaros E, et al. Cerebellar
ataxia in patients with mitochondrial DNA
disease: a molecular clinicopathological
study. J Neuropathol Exp Neurol 2012;
71: 148–61. doi: 10.1097/NEN.
0b013e318244477d
36. Leigh D. Subacute necrotizing encephalo-
myelopathy in an infant. J Neurol Neurosurg
Psychiatry 1951; 14: 216–21.
37. Dayan AD, Ockenden BG, Crome L. Necro-
tizing encephalomyelopathy of Leigh. Neu-
ropathological findings in 8 cases. Arch Dis
Child 1970; 45: 39–48.
38. Cavanagh JB, Harding BN. Pathogenic
factors underlying the lesions in Leigh’s
disease. Tissue responses to cellular
energy deprivation and their clinico-
pathological consequences. Brain 1994;
117: 1357–76.
39. Dinçer A, Ozyurt O, Kaya D, Kos¸ak E, Ozturk
C, Erzen C, et al. Diffusion tensor imaging of
Guillain-Mollaret triangle in patients with
hypertrophic olivary degeneration. J Neuro-
imaging 2011; 21: 145–51. doi: 10.1111/j.
1552-6569.2009.00461.x
40. Shah R, Markert J, Bag AK, Cur JK.
Diffusion tensor imaging in hypertrophic
olivary degeneration. AJNR Am J Neuro-
radiol 2010; 31: 1729–31.
BJR PS Bindu et al
8 of 8 bjr.birjournals.org Br J Radiol;87:20130478
